Calliditas Therapeutics AB (publ)

Calliditas Therapeutics AB (publ)verified

CALTX.ST

Price:

$208

Market Cap:

$11.24B

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis,...[Read more]

Industry

Biotechnology

IPO Date

2018-06-29

Stock Exchange

STO

Ticker

CALTX.ST

The PE Ratio as of November 2024 (TTM) for Calliditas Therapeutics AB (publ) (CALTX.ST) is -23.24

According to Calliditas Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -23.24. This represents a change of -43.63% compared to the average of -41.23 of the last 4 quarters.

Calliditas Therapeutics AB (publ) (CALTX.ST) Historical PE Ratio (quarterly & annually)

How has CALTX.ST PE Ratio performed in the past?

The mean historical PE Ratio of Calliditas Therapeutics AB (publ) over the last ten years is -31.91. The current -23.24 PE Ratio has changed 7.18% with respect to the historical average. Over the past ten years (40 quarters), CALTX.ST's PE Ratio was at its highest in in the September 2021 quarter at 190.43. The PE Ratio was at its lowest in in the December 2022 quarter at -334.41.

Quarterly (TTM)
Annual

Average

-31.91

Median

-16.17

Minimum

-85.84

Maximum

-11.25

Calliditas Therapeutics AB (publ) (CALTX.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Calliditas Therapeutics AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 406.81%

Maximum Annual PE Ratio = -11.25

Minimum Annual Increase = -83.28%

Minimum Annual PE Ratio = -85.84

Quarterly (TTM)
Annual
YearPE RatioChange
2023-14.6323.07%
2022-11.895.67%
2021-11.25-21.59%
2020-14.35-83.28%
2019-85.84406.81%
2018-16.944.77%
2017-16.17-70.55%
2016-54.88-10.36%

Calliditas Therapeutics AB (publ) (CALTX.ST) Average PE Ratio

How has CALTX.ST PE Ratio performed in the past?

The current PE Ratio of Calliditas Therapeutics AB (publ) (CALTX.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-12.59

5-year avg

-27.59

10-year avg

-31.91

Calliditas Therapeutics AB (publ) (CALTX.ST) PE Ratio vs. Peers

How is CALTX.ST’s PE Ratio compared to its peers?

Calliditas Therapeutics AB (publ)’s PE Ratio is less than Oncopeptides AB (publ) (-1.67), greater than BioArctic AB (publ) (-146.68), less than Hansa Biopharma AB (publ) (-3.35), less than Camurus AB (publ) (155.02), less than Bonesupport Holding AB (publ) (247.88),

Build a custom stock screener for Calliditas Therapeutics AB (publ) (CALTX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calliditas Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Calliditas Therapeutics AB (publ) (CALTX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Calliditas Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Calliditas Therapeutics AB (publ)'s PE Ratio?

How is the PE Ratio calculated for Calliditas Therapeutics AB (publ) (CALTX.ST)?

What is the highest PE Ratio for Calliditas Therapeutics AB (publ) (CALTX.ST)?

What is the 3-year average PE Ratio for Calliditas Therapeutics AB (publ) (CALTX.ST)?

What is the 5-year average PE Ratio for Calliditas Therapeutics AB (publ) (CALTX.ST)?

How does the current PE Ratio for Calliditas Therapeutics AB (publ) (CALTX.ST) compare to its historical average?